| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 04/13/2011 | CN1889920B Microcapsules with uv filter activity and process for producing them |
| 04/13/2011 | CN102015824A Carbohydrate lactone polymers |
| 04/13/2011 | CN102015672A Liquid crystalline compound with negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device |
| 04/13/2011 | CN102010391A Method for preparing high-purity delta decalactone |
| 04/13/2011 | CN102010281A Preparation method of alpha-acyloxy ether |
| 04/13/2011 | CN101497591B Preparation of 6-O-sulfonyl-glycal compound |
| 04/07/2011 | WO2011040509A1 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
| 04/07/2011 | WO2011038926A1 A process for preparing dihydropyran and its use as protective agent |
| 04/07/2011 | WO2011038910A1 Process for the preparation of dihydropyran |
| 04/07/2011 | US20110082200 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 04/07/2011 | CA2775962A1 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives |
| 04/07/2011 | CA2774040A1 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof |
| 04/06/2011 | EP2305661A1 Process for the preparation of 2,3-dihydropyran |
| 04/06/2011 | EP2305627A1 Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 04/06/2011 | CN1946680B 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2011 | CN102007110A Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders |
| 04/06/2011 | CN101289439B Process for preparing arabglycal |
| 04/05/2011 | US7919522 Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds |
| 03/31/2011 | US20110077380 Carbohydrate lactone polymers |
| 03/31/2011 | US20110077251 Novel 17 beta lupane derivatives |
| 03/30/2011 | EP2300449A1 Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative |
| 03/30/2011 | EP1178026B1 Processes for producing oxide with higher oxidation than alcohol |
| 03/30/2011 | CN101993428A Method for purifying ethyl maltol |
| 03/30/2011 | CN101348475B Novel method for synthesizing orlistat, intermediate compound and preparation thereof |
| 03/30/2011 | CN101279969B Organic electroluminescent material and application thereof |
| 03/29/2011 | US7915433 Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives |
| 03/29/2011 | US7915429 Compounds for the treatment of metabolic disorders |
| 03/29/2011 | US7915282 Preparation by intramolecular cyclization |
| 03/29/2011 | US7914862 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device |
| 03/29/2011 | CA2543250C Process for the preparation of ccr-2 antagonist |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/22/2011 | US7910751 Heterocyclidene acetamide derivative |
| 03/17/2011 | WO2011030591A1 Zinc cluster |
| 03/17/2011 | WO2011030160A1 Detection of mycobacteria |
| 03/17/2011 | WO2010144937A3 Intermediates for the preparation of octahydroquinolizines |
| 03/17/2011 | US20110065915 Catalysts for metathesis reactions including enantioselective olefin metathesis, and related methods |
| 03/17/2011 | CA2772588A1 Zinc cluster |
| 03/16/2011 | EP2295422A2 Glucopyranosyl substituted benzol derivatives, pharmaceutical compositions containing these compounds, use thereof and method for their production |
| 03/16/2011 | CN101041647B Novel production technique for linalool oxide |
| 03/15/2011 | CA2471814C Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 03/15/2011 | CA2450820C Processes for preparing calcium salt forms of statins |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2010136431A9 Spiro epoxides as intermediates |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | US7902383 Production method of heterocyclic mercapto compound |
| 03/08/2011 | US7902376 Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates |
| 03/03/2011 | US20110054193 Statin production |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110052504 Contrast agents |
| 03/02/2011 | EP1901731B1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 02/24/2011 | WO2011021534A1 Tetrahydropyran compounds, liquid crystal compositions and liquid crystal display elements |
| 02/24/2011 | US20110046375 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
| 02/23/2011 | CN101979388A Method for purifying barbaloin |
| 02/17/2011 | US20110039925 Cyclobutyl sulfones as notch sparing gamma secretase inhibitors |
| 02/17/2011 | US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/17/2011 | US20110037024 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device |
| 02/16/2011 | EP2284153A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284151A2 Substituted tetracycline compounds |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101977903A Preparation of sulfamide derivatives |
| 02/15/2011 | US7888519 Liquid crystals; using metastasis catalysts; reduction, hydrogenation |
| 02/15/2011 | US7888285 2,4,6-phenyl substituted cyclic ketoenols |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | CA2769563A1 Novel compounds as modulators of glucocorticoid receptors |
| 02/09/2011 | EP2280983A2 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/09/2011 | EP2280949A1 Novel pyran derivatives, their preparation and use thereof in perfumery |
| 02/09/2011 | EP2033637B1 Therapeutic or prophylactic agent for leukemia |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101969944A Pharmaceutical composition for treatment of fatty liver diseases |
| 02/09/2011 | CN101967134A Compound separated and extracted from marine penicillium sp.QY013 and application thereof |
| 02/03/2011 | WO2011014008A2 Novel 3-phenoxy-4-pyrone, 3-phenoxy-4-pyridone, or 4-pyridone derivatives, method for preparing same, and antimicrobial composition containing same as an active ingredient |
| 02/03/2011 | US20110024682 Liquid-crystalline medium and liquid-crystal display |
| 02/02/2011 | EP2278975A1 Novel nitroso compounds as nitroxyl donors and methods of use thereof |
| 02/02/2011 | CN101962375A Zanamivir intermediate azide reduction technical method |
| 01/27/2011 | WO2010136036A3 Calcium-sensing receptor-active compounds |
| 01/27/2011 | US20110021794 Process for the manufacture of epoxy triazole derivatives |
| 01/27/2011 | US20110021790 Producing biofuels using polyketide synthases |
| 01/27/2011 | US20110021592 Organic nanoparticles obtained from microemulsions by solvent evaporation |
| 01/26/2011 | EP2276479A2 Prodrugs of neuraminidase inhibitors |
| 01/26/2011 | EP2089361B1 Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 01/26/2011 | CN101959873A 5-hydroxy-2-methyl-4H-pyran-4-one-esters as novel tyrosinase inhibitors |
| 01/25/2011 | US7875737 Pyran derivatives, process of preparation and use thereof in perfumery and flavouring |
| 01/25/2011 | US7875707 combinatorial libraries; lipid solubility; solid phase synthesis |
| 01/25/2011 | US7875327 Liquid crystal compound having lactone ring, liquid crystal composition, and liquid crystal display device |
| 01/20/2011 | WO2011006208A1 Anti -influenza agents |
| 01/20/2011 | CA2768081A1 Anti-influenza agents |
| 01/19/2011 | CN101952453A ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof |
| 01/19/2011 | CN101168539B Method for extracting salvianolic acid B |
| 01/18/2011 | US7872127 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 01/18/2011 | US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates |
| 01/13/2011 | WO2011003976A1 CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL] BENZENE |
| 01/13/2011 | CA2767258A1 Crystallisation process for 1-(.beta.-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene |
| 01/12/2011 | EP2272838A1 Fostriecin derivatives and the pharmaceutical uses thereof |
| 01/12/2011 | EP2272837A1 Liquid crystalline compound with negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device |
| 01/12/2011 | EP2190827B1 N-benzyl-n'-arylcarbonylpiperazine derivatives as lxr modulators |
| 01/12/2011 | CN101190906B Method for preparing carthamin yellow carthamus B and application thereof |
| 01/12/2011 | CN101175777B (methyl)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern |